BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Primignani M, Tosetti G, La Mura V. Therapeutic and clinical aspects of portal vein thrombosis in patients with cirrhosis. World J Hepatol 2015; 7(29): 2906-2912 [PMID: 26689354 DOI: 10.4254/wjh.v7.i29.2906]
URL: https://www.wjgnet.com/1007-9327/full/v7/i29/2906.htm
Number Citing Articles
1
Xizheng Zhu, Beijia Chen, Hui Xu. By modulating miR‐525‐5p/Bax axis, LINC00659 promotes vascular endothelial cell apoptosisImmunity, Inflammation and Disease 2023; 11(1) doi: 10.1002/iid3.764
2
Qun Zhang, Renyong Guo, Yu Chen. D‐dimer level in liver transplant recipients on the first day after surgery is correlated with postoperative thrombosis recurrenceJournal of Clinical Laboratory Analysis 2019; 33(1) doi: 10.1002/jcla.22646
3
Jihyun Kwon, Youngil Koh, Su jong Yu, Jung-Hwan Yoon. Low-molecular-weight heparin treatment for portal vein thrombosis in liver cirrhosis: Efficacy and the risk of hemorrhagic complicationsThrombosis Research 2018; 163: 71 doi: 10.1016/j.thromres.2018.01.032
4
Alberto Zanetto, Krissia-Isabel Rodriguez-Kastro, Giacomo Germani, Alberto Ferrarese, Umberto Cillo, Patrizia Burra, Marco Senzolo. Mortality in liver transplant recipients with portal vein thrombosis - an updated meta-analysisTransplant International 2018; 31(12): 1318 doi: 10.1111/tri.13353
5
Anita Rajasekhar, Marc Zumberg. Consultative Hemostasis and Thrombosis2019; : 300 doi: 10.1016/B978-0-323-46202-0.00017-0
6
MohamedSalem Al Saeed, BilalO Al-Jiffry, Alaa Younes, Samir Badr, Tamer Abdel-Rahman, Mohamed Hatem, Mahmoud El-Meteini. Risk factors, pattern of presentation, methods of diagnosis, and results of treatment of acute portal vein thrombosis: A multicenter studySaudi Journal for Health Sciences 2019; 8(3): 182 doi: 10.4103/sjhs.sjhs_77_19
7
Meng Xu, Wanli Xue, Zhenhua Ma, Jigang Bai, Shengli Wu. Resveratrol Reduces the Incidence of Portal Vein System Thrombosis after Splenectomy in a Rat Fibrosis ModelOxidative Medicine and Cellular Longevity 2016; 2016: 1 doi: 10.1155/2016/7453849
8
Leona von Köckritz, Andrea De Gottardi, Jonel Trebicka, Michael Praktiknjo. Portal vein thrombosis in patients with cirrhosisGastroenterology Report 2017; 5(2): 148 doi: 10.1093/gastro/gox014
9
Arpit Taunk, Amar Mukund. Basics of Hepatobiliary Interventions2021; : 119 doi: 10.1007/978-981-15-6856-5_9
10
Hyeyoung Yang, Seo Ree Kim, Myeong Jun Song. Recurrent acute portal vein thrombosis in liver cirrhosis treated by rivaroxabanClinical and Molecular Hepatology 2016; 22(4): 499 doi: 10.3350/cmh.2016.0016
11
Andrea Mancuso. Portal Vein Thrombosis and Cirrhosis: The Role of AnticoagulationCurrent Hepatology Reports 2017; 16(2): 158 doi: 10.1007/s11901-017-0344-z
12
F. Chegai, A. U. Cavallo, M. Forcina, V. Giuricin, F. Castellani, L. Greco, M. Manuelli, T. M. Manzia, G. Sergiacomi. Giant Splenorenal Shunt in a Young Patient with Autoimmune Hepatitis/Primary Biliary Cholangitis Overlap Syndrome and Portal Vein ThrombosisCase Reports in Radiology 2017; 2017: 1 doi: 10.1155/2017/2167364
13
Gareema Tyagi, Roshan K Jha. Portal Vein Variations, Clinical Correlation, and Embryological Explanation: A Review ArticleCureus 2023;  doi: 10.7759/cureus.36400
14
Zheng Guo Xu, Li Tang, Yong Bing Zhao, Ming Fa Gao, Shi Ming Yang. Catheter‐directed thrombolysis combined with anticoagulation for acute extensive portal vein thrombosis: Our experienceJournal of Digestive Diseases 2018; 19(10): 635 doi: 10.1111/1751-2980.12649
15
Dan Zheng, Jiao Yu, Hui Li, Hongying Gan, Jun Wang, Ting Jiang, Huanping Ren, Fan Wu. Effects of transjugular intrahepatic portosystemic shunt treatment of patients with liver cirrhosis and portal hypertensionMedicine 2021; 100(27): e26610 doi: 10.1097/MD.0000000000026610
16
Andrea Mancuso. Management of portal vein thrombosis in cirrhosis: an updateEuropean Journal of Gastroenterology & Hepatology 2016; 28(7): 739 doi: 10.1097/MEG.0000000000000633